BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-197@pharmaconomics
DTSTAMP:20260707T003607Z
DTSTART;VALUE=DATE:20260802
DTEND;VALUE=DATE:20260803
SUMMARY:REPL PDUFA — RP1
DESCRIPTION:The FDA's approval decision on RP1 for melanoma is due Aug 2\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1737953/000110465926078511/tm2619129d1_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/197
URL:https://pharmaconomics.com/e/197
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:REPL catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR